1 September 2018 - The September 2018 issue of the Schedule of Pharmaceutical Benefits is out and now in effect.

The September issue of the Schedule includes a number of new/revised listings:

• Baricitinib (Olumiant) - new medicine
  
• Guanfacine hydrochloride (Intuniv) - new medicine
  
• Perfluorohexyloctane (NovaTears) - new medicine
  
• Quetiapine fumarate (multiple) - restriction change
  
• Triglycerides - medium chain (BetaQuik) - new formulation
  
• Triglycerides - long chain (CarbZero) - new formulation
  

Read Summary of Changes